|
HELQ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01616501271928E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72017955435422E-12 |
| Normal-vs-Stage2 |
3.57890000000083E-05 |
| Normal-vs-Stage3 |
1.38869999999347E-06 |
| Normal-vs-Stage4 |
4.434500E-02 |
| Stage1-vs-Stage2 |
1.175230E-01 |
| Stage1-vs-Stage3 |
7.370400E-01 |
| Stage1-vs-Stage4 |
2.131200E-01 |
| Stage2-vs-Stage3 |
2.839200E-01 |
| Stage2-vs-Stage4 |
9.159200E-01 |
| Stage3-vs-Stage4 |
3.929000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.33646435532364E-12 |
| Normal-vs-AfricanAmerican |
1.63929980701027E-10 |
| Normal-vs-Asian |
6.804400E-02 |
| Caucasian-vs-AfricanAmerican |
8.885800E-01 |
| Caucasian-vs-Asian |
9.180200E-01 |
| AfricanAmerican-vs-Asian |
9.603600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73805414505068E-12 |
| Normal-vs-Female |
4.8134995989102E-10 |
| Male-vs-Female |
3.198000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.06789999965562E-07 |
| Normal-vs-Extreme_Weight |
1.69264602334351E-12 |
| Normal-vs-Obese |
1.03310027199655E-10 |
| Normal-vs-Extreme_Obese |
1.433980E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.602200E-01 |
| Normal_Weight-vs-Obese |
6.945800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.582400E-01 |
| Extreme_Weight-vs-Obese |
4.627400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.829600E-01 |
| Obese-vs-Extreme_Obese |
5.977600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.960600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.66600067075251E-12 |
| Normal-vs-Age(61-80Yrs) |
5.56665824547053E-13 |
| Normal-vs-Age(81-100Yrs) |
7.48780037973518E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.672400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.818400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.182640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.664600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.929800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.641360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6556755966235E-12 |
| Normal-VS-Type2 PRCC |
4.57159865518975E-11 |
| Normal-VS-KIRP CIMP |
1.380020E-02 |
| Normal-VS-Unclassified PRCC |
2.37289999982515E-07 |
| Type1 PRCC-VS-Type2 PRCC |
9.921000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.079600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.693000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.400400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.016600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.603400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.27586829989923E-12 |
| Normal-vs-N1 |
9.972900E-04 |
| Normal-vs-N2 |
4.69790000001691E-06 |
| N0-vs-N1 |
2.626400E-02 |
| N0-vs-N2 |
5.133800E-01 |
| N1-vs-N2 |
1.684420E-01 |
|
|
